Spok Holdings, Inc. (NASDAQ: SPOK) is a healthcare communications company whose shares have shed roughly 39% over the past year, trading near their 52-week low at about $10.43. With a forward dividend yield near 12%, the stock looks inexpensive on an income basis, yet analyst coverage is unusually thin. The question for investors is whether the stock price can climb back toward the $14.50 level implied by the limited price targets on record.
SPOK has minimal sell-side coverage. Two price targets are on record, both from B. Riley Securities: a $15.00 target set by Kyle Bauser at initiation in September 2024 with a Neutral rating, and a $14.00 target set by Anderson Schock in February 2026, when the firm downgraded the stock to Neutral from Buy and cut its target from $21.00 to $14.00. The average of these two figures is $14.50, which serves as the central target used here. Because both targets come from a single firm and the $15.00 figure predates the downgrade, the aggregate should be treated with caution rather than as a robust Wall Street consensus.
The February 2026 downgrade captures the firm's current reasoning. B. Riley noted that peer multiples had compressed and that Spok was trading roughly in line with peers, while its margins and growth profile sat "well below peer averages," leaving limited upside. The analyst also highlighted the company's $1.25 annual dividend, equivalent to roughly a 9% yield at the time of the call and higher today after the share decline. There are no widely cited Buy ratings, and the most recent formal action is a Neutral stance.
Shares recently closed near $10.43, at the lower end of a 52-week range that spans from roughly $9.95 to the mid-to-high teens. To reach $14.50, the stock would need to climb about 39%, which qualifies as a very large move for a small-cap company with a market capitalization around $218 million and a trailing price-to-earnings (P/E) ratio in the high teens.
Fundamentally, Spok is a tale of two businesses. Its software operations — secure messaging, clinical alerting, and contact-center solutions for hospitals — are growing modestly, while its legacy wireless (paging) segment is shrinking. Management's fiscal 2026 guidance calls for revenue of $136 million to $143 million, roughly flat at the midpoint, with software growth of about 4% offset by a similar decline in wireless. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) guidance is $27.5 million to $32.5 million. A path toward $14.50 would likely require software momentum to outpace the wireless decline and a re-rating of the shares.
The $9.95 area represents a meaningful support level, marking the 52-week low and a zone that has held during the recent decline. On the upside, the stock's prior highs in the mid-to-high teens now function as resistance; a sustained advance toward $14.50 would require reclaiming a substantial portion of the multi-month decline. The roughly $14 level, matching the most recent analyst target, also stands as a notable psychological and technical hurdle.
Price targets generally reflect a research horizon of around 12 months, though B. Riley has not published a precise stated horizon for SPOK. Investors should watch the next quarterly earnings report, scheduled for late October 2026, along with software bookings growth, the pace of wireless erosion, dividend coverage, and any analyst rating or target revisions. Broader healthcare-IT spending trends and interest-rate shifts, which influence the relative appeal of high-yield equities, also matter.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor existing positions, and spot emerging trend changes more efficiently than manual screening. For a thinly covered name like SPOK, where analyst updates are infrequent, pairing a real-time signal tool with fundamental research can help investors stay ahead of shifts in momentum.
The $14.50 target is the average of just two B. Riley Securities price targets, a $14 to $15 range that reflects limited, cautious coverage rather than a broad analyst consensus. Reaching it would require roughly a 39% advance from about $10.43 — a very large move for a flat-revenue company whose legacy wireless business is shrinking. The stock's near-12% dividend yield and improving software bookings are genuine supports, but flat guidance, a recent earnings miss, and below-peer margins and growth are meaningful obstacles. With a Neutral rating and minimal coverage, the outlook hinges on whether software acceleration can finally outweigh wireless declines. Investors should monitor upcoming earnings and any revisions closely, but no outcome is guaranteed.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, SPOK has been loosely correlated with EVTC. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SPOK jumps, then EVTC could also see price increases.
| Ticker / NAME | Correlation To SPOK | 1D Price Change % | ||
|---|---|---|---|---|
| SPOK | 100% | +0.58% | ||
| EVTC - SPOK | 41% Loosely correlated | +11.10% | ||
| DOX - SPOK | 37% Loosely correlated | -30.07% | ||
| QLYS - SPOK | 36% Loosely correlated | +0.15% | ||
| EEFT - SPOK | 36% Loosely correlated | +6.66% | ||
| OSPN - SPOK | 34% Loosely correlated | -3.23% | ||
More | ||||
| Ticker / NAME | Correlation To SPOK | 1D Price Change % |
|---|---|---|
| SPOK | 100% | +0.58% |
| Services to the Health Industry industry (42 stocks) | 11% Poorly correlated | -3.64% |
| Health Services industry (239 stocks) | 4% Poorly correlated | -4.59% |